胎盘植入谱系疾病的分娩时机:泛美胎盘植入谱系疾病学会的经验
该回顾性多中心研究纳入744例产前诊断且组织病理学确诊的胎盘植入谱系疾病患者,评估按母胎医学会推荐孕周(34 0/7至35 6/7周)分娩的依从性。488例(66%)为计划分娩,但仅252例(39%)在推荐窗口内分娩;计划分娩亚组中209例(49%)在窗口内。推荐窗口内与窗口前后2周分娩的母体结局相似。
要点
- 仅39%的产前诊断胎盘植入谱系疾病患者在推荐孕周34 0/7至35 6/7周内分娩。
- 计划分娩患者中49%在推荐窗口内分娩,28%早于34周,23%在36周或之后。
- 推荐窗口内与窗口前后2周分娩的母体结局相似,与疾病严重程度无关。
核心结论
- 不足一半的胎盘植入谱系疾病患者在推荐孕周34 0/7至35 6/7周内计划分娩。
- 偏离推荐的原因以及基于危险因素和预测结局的个体化分娩时机的风险与获益需进一步研究。
研究设计与样本
- 回顾性多中心研究,数据来自泛美胎盘植入谱系疾病学会的转诊中心。
- 纳入产前诊断且组织病理学确诊的胎盘植入谱系疾病患者744例。
- 评估对母胎医学会推荐分娩孕周窗口的依从性,并按计划分娩与非计划分娩分层。
- 比较推荐窗口内与窗口前后2周计划分娩患者的结局。
主要发现
- 744例中488例(66%)为计划分娩。
- 所有产前诊断患者中252例(39%)在推荐窗口34 0/7至35 6/7周内分娩。
- 计划分娩亚组(n=426)中209例(49%)在窗口内分娩,120例(28%)早于34周,97例(23%)在36周或之后分娩。
- 计划分娩的胎盘植入患者中27%在推荐窗口后2周(36 0/7-37 6/7周)分娩。
- 计划分娩的植入/穿透性胎盘植入患者中22%在推荐窗口前2周(32 0/7-33 6/7周)分娩。
临床怎么用
- 母胎医学会推荐对产前疑似胎盘植入谱系疾病者在34 0/7至35 6/7周晚早产期行剖宫产并可能行子宫切除术。
- 本研究显示该推荐孕周窗口的临床依从性有限。
局限性
- 偏离推荐的原因以及基于危险因素和预测结局的个体化分娩时机的风险与获益需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Society for Maternal-Fetal Medicine recommends cesarean delivery with potential hysterectomy scheduled in the late preterm period between 34 0/7 and 35 6/7 weeks of gestation for prenatally suspected placenta accreta spectrum. OBJECTIVES: We aimed to investigate clinical compliance with the recommended delivery timing window for placenta accreta spectrum and its impact on maternal and neonatal outcomes. STUDY DESIGN: We performed a retrospective multicenter review of data from referral centers within the Pan-American Society for Placenta Accreta Spectrum. Patients with placenta accreta spectrum with both antenatal diagnosis and confirmed histopathologic findings were included. We investigated adherence to the Society for Maternal-Fetal Medicine-recommended gestational age window for delivery, and compliance was further stratified by scheduled and unscheduled delivery. We compared the outcomes for patients with scheduled delivery within vs immediately 2 weeks outside the recommended window. RESULTS: Among 744 patients with a prenatal diagnosis of placenta accreta spectrum and placental histopathologic confirmation, 488 (66%) had scheduled delivery. Among all prenatally diagnosed placenta accreta spectrum patients, 252 (39%) delivered within the recommended window of 34 0/7 and 35 6/7 weeks gestation. For the subgroup of patients who underwent scheduled delivery (n=426), 209 (49%) had delivery in this window, 120 (28%) delivered before 34 weeks, and 97 (23%) delivered at or later than 36 weeks. In the patients with scheduled delivery, 27% of placenta accreta spectrum patients with accreta delivered in the 2 weeks immediately after the recommended window (36 0/7-37 6/7 weeks), and 22% of placenta accreta spectrum pregnancies with increta/percreta delivered in the 2 weeks immediately before the recommended delivery (32 0/7-33 6/7 weeks). The maternal outcomes among those who delivered within the recommended range vs those delivering 2 weeks before and after the recommended range were similar, regardless of placenta accreta spectrum severity. CONCLUSION: Less than half of placenta accreta spectrum patients had scheduled delivery within the recommended gestational age of 34 0/7 to 35 6/7 weeks. The reasons for deviation from recommendations and the risks and benefits of individualized timing of delivery on the basis of risk factors and predicted outcomes warrant further investigation.
引用
- Salmanian B, Einerson BD, Carusi DA, et al. Timing of delivery for placenta accreta spectrum: the Pan-American Society for the Placenta Accreta Spectrum experience. Am J Obstet Gynecol MFM. 2022. PMID: 35977702. doi:10.1016/j.ajogmf.2022.100718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。